The world is being quietly rearranged by people who write very long documents.


The title they went with Medical Devices; Immunology and Microbiology Devices; Classification of the Postnatal Chromosomal Copy Number Variation Detection System Noisy translates that to

US health regulators loosen rules for newborn genetic tests


US health regulators are making it easier to approve devices that detect genetic variations in newborns. This means manufacturers can bring these tests to market faster, potentially giving parents more options.
Genetic tests for newborns previously faced the highest level of regulatory scrutiny, which slowed down their availability. This change moves them into a category with specific, but less burdensome, requirements. Companies can now develop and sell these tests more quickly, which could increase their use in diagnosing conditions in infants.
Watch how many new postnatal chromosomal copy number variation detection systems get approved in the next 12-24 months compared to previous years.

If you insist
Read the original →